At this year’s virtual J.P. Morgan Healthcare Conference, we presented key achievements and announced Vision 2025 to deliver sustainable growth and enhanced value. Guided by our patient-centric approach, Jazz is committed to taking bold steps to deliver life-changing therapies that create new or better standards of care.
Bruce Cozadd, our Chief Executive Officer, looks back on Jazz’s major achievements of 2021 amid ongoing challenges of the pandemic, reflecting on the significant strides made for patient populations, and reinstating Jazz’s continued commitment to developing breakthrough therapeutics as we kick off 2022.
Jazz Pharmaceuticals is a global biopharmaceutical company dedicated to bringing life-changing medicines to people with limited or no options, so they can live their lives more fully.
By unlocking biopharmaceutical discoveries to develop novel medicines, we are giving thousands of people around the world the opportunity to redefine what’s possible.
Thank you for visiting JazzPharma.com. The site you are about to visit is maintained by a third party who is solely responsible for its content; Jazz Pharmaceuticals is not responsible for the content or privacy practices of any third-party websites. Click Cancel to return or OK to continue.
You are now leaving www.JazzPharma.com. Thank you for visiting. The information on the website you are entering is intended for visitors in the United States only.
